Metraipolis › archive › dc_ea1240e227b0

Design Considerations for a Phase II Platform Trial in Major Depressive Disorder — Europe PMC PMID:40864526

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40864526
DOI
10.1002/pst.70025
License (as archived)
solo-consultazione
Archived
2026-11-10T05:02:44.030Z
SHA-256 of the archived text
eab3b3c58e91842cce3d28995ab1785905e0ef7da17bcdbc9048ee4772f15b1f
Stable URL of this page
https://metraipolis.com/documento/dc_ea1240e227b0

How to cite

Design Considerations for a Phase II Platform Trial in Major Depressive Disorder — Europe PMC PMID:40864526 — Europe PMC (en), https://europepmc.org/article/MED/40864526 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ea1240e227b0 (Metraipolis archive dc_ea1240e227b0, sha256 eab3b3c58e91842cce3d28995ab1785905e0ef7da17bcdbc9048ee4772f15b1f)
BibTeX
@misc{dcea1240e227b0,
  title = {Design Considerations for a Phase II Platform Trial in Major Depressive Disorder — Europe PMC PMID:40864526},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40864526},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ea1240e227b0; sha256 eab3b3c58e91842cce3d28995ab1785905e0ef7da17bcdbc9048ee4772f15b1f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40864526. Agents can read the archived copy with the MCP tool read_document.